Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections

This study has been completed.
Information provided by (Responsible Party):
Bayer Identifier:
First received: May 9, 2008
Last updated: October 10, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2004
  Estimated Primary Completion Date: No date given